PRESS RELEASE published on 10/21/2025 at 07:25, 2 months 9 days ago EQS-Adhoc: FRIEDRICH VORWERK grows by 39% in Q3/25 to €202 million in revenue with an EBITDA margin of 25,4% and raises its 2025 forecast to €650-680 million revenue with an EBITDA margin of 20,0-22,0% FRIEDRICH VORWERK grows revenue by 39% in Q3/25 to €202 million, EBITDA margin at 25.4%, raises 2025 forecast to €650-680 million revenue with EBITDA margin 20.0-22.0% Revenue Growth EBITDA Margin Friedrich Vorwerk Energy Infrastructure 2025 Forecast
PRESS RELEASE published on 10/21/2025 at 07:15, 2 months 9 days ago Inside Information / News release on accounts, results Eurofins reports 4.0% organic revenue growth in 9M 2025, with solid full-year outlook. CEO expects margin expansion amidst foreign exchange challenges Financial Performance Organic Revenue Growth Margin Expansion Eurofins FY 2025 Objectives
REGULATED PRESS RELEASE published on 10/21/2025 at 07:05, 2 months 9 days ago Edenred and Visa announce a strategic partnership to accelerate innovation across Benefits and Engagement, Mobility, and B2B Payment Solutions Edenred and Visa announce a strategic partnership to drive innovation and expand their reach in commercial and consumer payment ecosystems. The collaboration strengthens Edenred's platform through the certification of its in-house issuing and processing infrastructure with Visa Europe Edenred Innovation Payment Solutions Strategic Partnership Visa
PRESS RELEASE published on 10/21/2025 at 07:00, 2 months 9 days ago Sonova expands AI leadership with innovations debuting at EUHA 2025 Sonova Holding AG introduces Infinio Ultra Sphere and enhanced Infinio hearing aid range at EUHA 2025, focusing on speech clarity, extended battery life, and innovative wax management system Sonova Holding AG Hearing Aids Infinio Ultra Sphere Speech Clarity AI Chip
REGULATED PRESS RELEASE published on 10/21/2025 at 07:00, 2 months 9 days ago Edenred reports higher growth in its activity in the third quarter of 2025 compared to the first half of the year Edenred reports strong revenue growth in third-quarter 2025, with total revenue reaching €726 million, up 7.3% like-for-like. Operating revenue up 8.2%, driven by growth across all business lines and regions Edenred Revenue Growth Business Lines Operating Revenue Q3 2025
REGULATED PRESS RELEASE published on 10/21/2025 at 07:00, 2 months 9 days ago 2025 nine-month sales. €710m at constant exchange rates (+4.4%) Interparfums reports €710m sales in first nine months of 2025, up 4.4% at constant exchange rates. Strong performance in flagship brands with Jimmy Choo fragrances driving growth Sales Interparfums Growth Fragrances 2025
PRESS RELEASE published on 10/21/2025 at 06:45, 2 months 9 days ago HUBER+SUHNER achieves significantly higher order intake in the first nine months of 2025 HUBER+SUHNER achieves significantly higher order intake in the first nine months of 2025, with Communication segment leading the growth. Net sales reach prior-year level Net Sales Order Intake HUBER+SUHNER Industry Segment Communication Segment
PRESS RELEASE published on 10/21/2025 at 06:32, 2 months 9 days ago Q3 2025: Solid Group revenue Q3 2025: Solid Group revenue with Eurotunnel revenue up 3%. Eleclink revenue down 13%. Europorte revenue up 5%. CEO confirms EBITDA target Group Revenue ElecLink EBITDA Target Eurotunnel Q3 2025
PRESS RELEASE published on 10/21/2025 at 06:30, 2 months 9 days ago Formycon’s FYB201/Ranivisio® sets innovative standard as Europe’s First Ranibizumab Biosimilar available in Pre-filled Syringe Formycon's FYB201/Ranivisio® is Europe's First Ranibizumab Biosimilar available in Pre-filled Syringe, offering improved handling, accuracy, and convenience for applicants. Teva to commercialize across Europe Europe Biosimilar Formycon Teva Ranivisio
PRESS RELEASE published on 10/21/2025 at 05:28, 2 months 9 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC The Vanguard Group, Inc. discloses 3.57% stake in Spire Healthcare Group PLC. Purchase of 1p ordinary shares. Disclosure under Rule 8.3 of the Code Rule 8.3 Vanguard Group Stake Disclosure 1p Ordinary Shares Spire Healthcare Group
Published on 12/30/2025 at 03:20, 6 hours ago Clean Air Metals Files Interim Financial Statements for the Nine Months Ended October 31, 2025
Published on 12/29/2025 at 23:30, 9 hours 50 minutes ago Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/29/2025 at 20:45, 12 hours 35 minutes ago Taranis Details What Lies Under Thor - A Lamprophyre Intrusive and Related Alteration That Has Direct Affiliation with Calc-Alkaline Epithermal Deposits
Published on 12/29/2025 at 11:00, 22 hours 20 minutes ago New LiDAR Survey Completion Accelerates Planning and Engineering Work at La Blache and Lac Brule
Published on 12/26/2025 at 14:00, 3 days 19 hours ago Loar Holdings Inc. Announced The Completion of its Acquisition of LMB Fans & Motors
Published on 12/30/2025 at 09:15, 5 minutes ago Inside China | Kishore Mahbubani: APEC meeting in Shenzhen could inspire global development
Published on 12/30/2025 at 09:05, 15 minutes ago Dstny Microsoft Teams integration Facilitates 445 Million Calls in 2025 as Platform Adoption Accelerates
Published on 12/30/2025 at 09:05, 15 minutes ago Energy for All: SINEXCEL Turns Sustainability Commitments into Action
Published on 12/29/2025 at 18:05, 15 hours 15 minutes ago Covivio - Treasury shares transactions between December 22nd , 2025 and December 24th, 2025
Published on 12/29/2025 at 17:35, 15 hours 45 minutes ago Disclosure of transactions in own shares from December 22 to December 24, 2025
Published on 12/22/2025 at 18:05, 7 days 15 hours ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 17:35, 7 days 15 hours ago DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 15 TO DECEMBER 19, 2025